Immunotherapy: the future of science and medicine?
Immunotherapy is a diverse and broad catch-all for any treatments and therapies that utilize the patient’s own immune response to mount a defense.
Webinar On-Demand: Cell Therapy Development for Solid Tumors
In this webinar, we highlight a variety of assays to support the development of cell therapies for solid tumors.
Improving the viral plaque assay speed, sensitivity and robustness using imaging cytometry
Improved fluorescent plaque assay method using fluorescently-labeled antibodies and the use of the Celigo image cytometer.
Addressing Primary Cell Counting Concerns
Everyone I meet that performs primary cell counting wants to optimize the amount of time they spend doing that task. They also agree that 30 seconds per count sounds pretty good.
Identify & Resolve Manual Cell Counting Errors through Automation
The use of modern automation has largely eliminated many of the hemocytometer's sources of error, increasing the accuracy and efficiency of cell counting today.
Improve Seahorse XF results using direct cell counting
Improve Seahorse XF results using direct cell counting. An important step in performing SeahorseTM XF cell metabolism analysis is normalization of the resultant data.
Accurate Cell Counting is Important for ELISpot
ELISpot is an assay for the detection and enumeration of cytokine secreting cells. Accurate cell counting is important for ELISpot.
Your Workflow: Before and After Cellaca MX
Cellaca MX High Speed, High Throughput Cell Counter This video will show you how Cellaca MX will change your workflow. With speeds as quick as 48 seconds for 24 samples, this cell counter is a game changer. Learn more about the Cellaca MX here or Request a Demo
New from Nexcelom at SLAS2019
Come see what's new! High speed, high throughput cell counter. 24 Samples per plate 50 ul - 200 ul/sample Viability: trypan blue or fluorescent dyes Count cell lines & primary cells Automation ready Booth #1250 | Washington DC | February 2-6 Learn More!
Nexcelom’s CTO on the Future of CAR T Workflow
Nexcelom founder and CTO, Dr. Jean Qiu, describes 3 major reasons why we partner with global and local research organizations to streamline CAR-T workflow.